Psychological Comorbidities Predicting Prescription Opioid Abuse among Patients in Chronic Pain Presenting to the Emergency Department

Woolf, 2004, Use and abuse of opioid analgesics: Potential methods to prevent and deter non-medical consumption of prescription opioids, Curr Opin investig Drugs, 5, 61

10.1111/j.1526-4637.2004.04049.x

National Survey on Drug Use and Health. The NSDUH Report: Nonmedical Use of Prescription Pain Relievers. Office of Applied Studies. 2004. Available at: http://www.oas.samhsa.gov/2k4/pain/pain.pdf. (Accessed December 10, 2007).

10.1016/S0376-8716(03)00003-6

10.1016/j.berh.2005.03.002

10.1097/01.brs.0000157414.47713.78

10.1016/S0304-3959(02)00045-3

10.1023/B:JOBM.0000019849.21524.70

10.1016/0304-3959(86)90074-6

Fernandez, 2001, Benzodiazepine addiction and symptoms of anxiety and depression in elderly subjects, Encephale, 27, 459

Abbott, 1998, Use and abuse of over-the-counter analgesic agents, J Psychiatry Neurosci, 23, 13

10.1177/089198879600900204

10.1081/ADA-120002975

10.1016/j.jpainsymman.2004.04.007

10.1016/j.pain.2004.07.026

10.1001/archpsyc.1961.01710120031004

Beck, 1974, Short form of depression inventory: Cross-validation, Psychol Rep, 34, 1184, 10.1177/003329417403403s01

McDowell I . Measuring Health, 2nd edition. New York: Oxford University Press; 1996:245.

Spielberger CD Gorsuch RL Lushene RE . Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist Press; 1970.

10.1001/archpsyc.1992.01820080032005

10.1001/archpsyc.1992.01820080038006

10.1111/j.1600-0447.1991.tb03123.x

10.1176/ajp.147.8.1043

10.1016/0010-440X(92)90001-7

Little, 2004, Robust Liklihood Based Analysis of Multivariate Data with Missing Values, Statistica Simca, 14, 949

10.1001/archinte.163.20.2433

10.3109/00952999809001548

10.2165/00023210-200418010-00002

10.1001/archinte.166.19.2087

10.1016/j.pain.2005.09.020

10.1001/jama.289.18.2370

10.1097/AJP.0b013e3180330dc5

10.1016/j.addbeh.2005.07.012

10.1176/appi.ps.56.8.927

10.1097/01.ajp.0000210926.41406.2c

10.1053/comp.2002.33500

Brady KT Verduin ML . Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Subst Use Misuse 2005;40:2021–41, 2043–8.

10.1081/ADA-100100599

10.1016/S0304-3959(03)00301-4

10.1097/00007632-199301000-00011

Fishbain, 2005, Polypharmacy treatment approaches to the psychiatric and somatic comorbidities found in patients with chronic pain, Am J Phys Med Rehabil, 84, S56, 10.1097/01.PHM.0000154904.83278.32

Ward, 2004, Assessment and management of personality disorders, Am Fam Physician, 70, 1505

10.1176/appi.ajp.162.3.621

10.1016/j.biopsych.2004.11.044

Bogenschutz, 2004, Olanzapine versus placebo in the treatment of borderline personality disorder, J Clin Psychiatry, 65, 104, 10.4088/JCP.v65n0118

10.1007/s11920-004-0041-9

10.1016/S0010-440X(03)00147-0

10.1016/j.rapm.2004.11.005

10.1016/S0376-8716(00)00148-4

10.1097/00002508-199206000-00003

10.1097/00002508-199706000-00009

10.1046/j.1525-1497.2002.10435.x

10.1016/j.jpain.2005.04.004

Passik, 2006, Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation, J Pain Palliat Care Pharmacother, 20, 5, 10.1080/J354v20n02_03

10.1186/1472-6963-6-46

10.1016/j.pain.2005.08.006